Summary: Human induced pluripotent stem (iPS) cells were differentiated into the endoderm using activin A and were then treated with fibroblast growth factor 2 (FGF2) for differentiation into intestinal stem cell-like cells. These immature cells were then differentiated into enterocyte-like cells using epidermal growth factor (EGF) in 2% fetal bovine serum (FBS). At the early stage of differentiation, mRNA expression of caudal type homeobox 2 (CDX2), a major transcription factor related to intestinal development and differentiation, and leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), an intestinal stem cell marker, was markedly increased by treatment with FGF2. When cells were cultured in medium containing EGF and a low concentration of FBS, mRNAs of specific markers of intestinal epithelial cells, including sucrase isomaltase, the intestinal oligopeptide transporter SLC15A1/peptide transporter 1 (PEPT1), and the major metabolizing enzyme CYP3A4, were expressed. In addition, sucraseisomaltase protein expression and uptake of ¢-Ala-Lys-N-7-amino-4-methylcoumarin-3-acetic acid (¢-Ala-Lys-AMCA), a fluorescence-labeled substrate of the oligopeptide transporter, were detected. These results demonstrate a simple and direct method for differentiating human iPS cells into functional enterocyte-like cells.
Introduction
The small intestine and liver play important roles in all aspects of pharmacokinetics, including drug disposition, drug metabolism, drug transport, drug interactions, and bioavailability. Because drug-metabolizing enzymes such as cytochrome P450 (CYP) and UDP-glucuronyltransferase (UGT) and drug transporters such as ATP-binding cassette (ABC) and solute carrier (SLC) transporters are appreciably expressed in the small intestinal epithelia, 1, 2) it is necessary to estimate intestinal metabolism and absorption during the early stages of drug development. To this end, various in vivo and in vitro systems have been employed to assess the intestinal first-pass effect. However, extrapolation of experimental animal data to humans is often hampered by species differences, and primary human intestinal cells are rarely available. Therefore, a system that accurately and easily estimates intestinal membrane permeability and metabolism is urgently required.
Human induced pluripotent stem (iPS) cells can be generated by transducing reprogramming factors (OCT3/4, SOX2, KLF4, c-MYC) into somatic cells 3) and these cells share many characteristics of embryonic stem (ES) cells. 4) Human iPS cells are expected to be useful not only in regenerative medicine but also in pharmacokinetic and toxicokinetic drug development studies because their use is not as ethically regulated as that of human ES cells.
Therefore, human iPS cells have been differentiated into various cell types, including pancreatic cells, 5, 6) neuron cells, 7) cardiomyocytes, 8) and hepatocytes. [9] [10] [11] [12] [13] A few studies report the differentiation of iPS cells into enterocytes. In particular, mouse iPS cells were differentiated into a gutlike organ following the formation of embryoid bodies (EBs), 14) and human iPS cells were differentiated into intestinal tissue using a culture method for intestinal crypt stem cells. 15) However, functional characteristics of drug transporters and drug-metabolizing enzymes of differentiated cells are almost entirely unexplored in these reports. Thus, whether differentiated intestinal tissue or organoids can be used in drug development studies, particularly studies of the absorbability and metabolic capacity of drugs, remains unclear.
The small intestinal epithelium comprises absorptive cells, goblet cells, endocrine cells, and Paneth cells. Several signaling pathways such as Notch, Wnt, phosphoinositide 3-kinase, and bone morphogenic protein signaling are associated with intestinal development.
16) Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5) has been identified as an intestinal stem cell marker. 17) Indeed, this was also observed in mouse LGR5-positive cells that formed a crypt-villus structure in vitro. 18) Improvements in this technique have enabled long-term culture of human epithelial cells isolated from the small intestine, 19) leading to advances in intestinal stem cell research. However, mechanisms of intestinal development are not sufficiently understood, and it is difficult to control differentiation into all four cell types.
In this study, we established a functional enterocyte-like cell line from human iPS cells for use in drug development studies. We propose a simple and direct differentiation method by twodimensional culture. Our data may facilitate the development of an intestinal pharmacokinetic analysis system to identify safe drugs with favorable pharmacokinetic characteristics.
Materials and Methods
Materials: FGF2, FGF4, activin A, and epidermal growth factor (EGF) were purchased from PeproTech Inc. (Rocky Hill, NJ). Wnt3a was purchased from R&D Systems, Inc. (Minneapolis, MN). BD Matrigel matrix Growth Factor Reduced (Matrigel) was purchased from BD Biosciences (Bedford, MA). Affinityisolated rabbit polyclonal antihuman sucrase-isomaltase antibody and intestinal recombinant protein epitope signature tags were purchased from Sigma-Aldrich Co. (St. Louis, MO). The purified IgG fraction of polyclonal goat antiserum against rabbit IgG conjugated with Alexa Fluor 568 and KnockOut Serum Replacement (KSR) were purchased from Invitrogen Life Technologies Co. (Carlsbad, CA). ¢-Ala-Lys-N-7-amino-4-methylcoumarin-3-acetic acid (¢-Ala-Lys-AMCA) was purchased from BIOTREND Chemicals (Destin, FL), and (+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride (Y-27632) was purchased from Wako Pure Chemical Industries (Osaka, Japan). Human adult small intestine total RNA from a 66-year-old male donor was purchased from BioChain Institute Inc. (Newark, CA). Murine embryonic fibroblasts (MEFs) were obtained from Oriental Yeast Co. (Tokyo, Japan). The RNeasy Mini Kit was purchased from Qiagen (Valencia, CA). The PrimeScript RT Reagent Kit and TaKaRa SYBR Premix EX Taq II were purchased from Takara Bio Inc. (Otsu, Japan). All other reagents were of the highest quality available.
Human iPS cell cultures: A human iPS cell line (Windy) was provided by Dr. Akihiro Umezawa of the National Center for Child Health and Development. Human iPS cells were maintained in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's nutrient mixture F-12 (DMEM/F12) containing 20% KSR, 2 mM L-glutamine, 1% MEM nonessential amino acid solution (NEAA), 0.1 mM 2-mercaptoethanol, and 5 ng/ml FGF2 at 37°C in humidified air with 5% CO 2 . The human iPS cells were cultured on a feeder layer of mitomycin C-treated MEFs, and the medium was changed every day.
Differentiation into enterocyte-like cells: The human iPS cells were used for differentiation studies between passages 30 and 50. When the cells reached approximately 70% confluence, differentiation was initiated by replacing the medium with Rosewell Park Memorial Institute (RPMI) 1640 medium containing 2 mM GlutaMAX, 0.5% fetal bovine serum (FBS), 100 ng/ml activin A (a member of the transforming growth factor-¢ family that is known to efficiently induce differentiation into the definitive endoderm), 20, 21) 100 units/ml penicillin, and 100 µg/ml streptomycin. After 48 h, the medium was replaced with RPMI 1640 containing 2 mM GlutaMAX, 2% FBS, 100 ng/ml activin A, 100 units/ml penicillin, and 100 µg/ml streptomycin, and the cells were cultured for 24 h. Subsequently, the culture medium was replaced with DMEM/F12 containing 2% FBS, 2 mM GlutaMAX, and 250 ng/ml FGF2 or FGF4 with or without 50 ng/ml Wnt3a for 96 h. The cells were then treated for 1 h with the selective Rho-associated kinase inhibitor Y-27632 at 10 µM. 22, 23) The cells were then passaged on Matrigelcoated 24-well plates and cultured in DMEM/F12 containing 2% or 10% FBS, 2% B-27 supplement, 1% N2 supplement, 1% NEAA, 2 mM L-glutamine, antibiotics (100 units/ml penicillin and 100 µg/ml streptomycin), and 20 ng/ml EGF for 1, 4, 13, or 19 days. Y-27632 was added at 10 µM during the initial 24 h of culture. The medium was changed every 3 days (Fig. 1) .
RNA extraction and reverse transcription reaction: Total RNA was isolated from differentiated iPS cells using the RNeasy Mini Kit. First-strand cDNA was prepared from 500 ng of total RNA. The reverse transcription reaction was performed using the PrimeScript RT Reagent Kit according to the manufacturer's instructions.
Real-time polymerase chain reaction (PCR) analysis: Relative mRNA expression levels were determined using SYBR Green real-time quantitative reverse transcription-PCR (RT-PCR). Realtime PCR analysis was performed on the Applied Biosystems 7300 Real Time PCR System using 7300 System SDS software version 1.4 (Applied Biosystems, Carlsbad, CA). PCR was performed with the primer pairs listed in Table 1 using SYBR Premix EX Taq II. mRNA expression levels were normalized relative to that of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Fig. 1. Schematic of the protocol for the differentiation of human iPS cells into enterocytes
Human iPS cells were cultured in the presence of activin A (100 ng/ml) for 3 days. The cells were further cultured in medium containing FGF2 (250 ng/ml) or FGF4 (250 ng/ml) with or without Wnt3a (50 ng/ml) for 4 days. After 7 days of differentiation, the cells were treated with Y-27632 (10 µM), passaged, and subsequently cultured in the presence of 2% or 10% FBS and EGF (20 ng/ml) for 19 days.
Immunofluorescence staining: The cells differentiated with FGF2 and 2% FBS were washed three times with phosphatebuffered saline (PBS) without calcium or magnesium, fixed for 30 min at room temperature in 4% paraformaldehyde, and permeabilized in PBS containing 0.1% Triton X-100 for 5 min at room temperature. After being washed three times with PBS, the cells were blocked in PBS with 2% skim milk for 20 min at room temperature and were incubated with antisucrase-isomaltase antibody diluted at 1:200 for 60 min at room temperature. Rabbit serum was used as a negative control. The cells were washed three times with PBS and incubated with a 1:500 dilution of Alexa Fluor 568-labeled secondary antibody for 60 min at room temperature. After being washed three times with PBS, the cells were incubated with 1 µg/ml 4A,6-diamidino-2-phenylindole (DAPI) for 5 min at room temperature and washed with PBS. The cells were mounted on a glass slide using a 9:1 mixture of glycerol and PBS and viewed using an LSM 510Meta confocal microscope (Carl Zeiss Inc., Oberkochen, Germany).
Uptake study of ¢-Ala-Lys-AMCA: The cells differentiated with FGF2 and 2% FBS were rinsed several times with PBS and incubated with DMEM/F12 containing 25 µM ¢-Ala-Lys-AMCA for 4 h at 37°C. After incubation, uptake of ¢-Ala-Lys-AMCA was stopped by washing with ice-cold PBS. The cells were fixed for 30 min at room temperature in 4% paraformaldehyde, and immunofluorescence staining was performed using the primary and secondary antibodies as described above. The cells were then mounted using a 9:1 mixture of glycerol and PBS and viewed using an LSM 510Meta confocal microscope.
Statistical analysis: Levels of statistical significance were assessed using Student's t-test, and multiple comparisons were performed using analysis of variance (ANOVA) followed by Tukey's test.
Results
Early stages of differentiation into intestinal cells: For efficient, selective, and direct differentiation, a protocol designed to mimic intestinal development is desirable. We attempted differentiation into enterocytes that mediate the formation of the definitive endoderm. Because the intestine is an endoderm-derived organ, the human iPS cells were initially differentiated into the endoderm using a high concentration of activin A (100 ng/ml). Subsequently, we investigated the effects of FGF2, FGF4, and Wnt3a, which promote the development of mid-and hindgut lineages, 24, 25) during differentiation from the definitive endoderm to intestinal stem cells. In these experiments, mRNA expression of caudal type homeobox 2 (CDX2), a major transcription factor of intestinal development and cell differentiation, 26, 27) was slightly higher in FGF4-treated cells than that in FGF2-treated cells ( Fig. 2A) . In contrast, mRNA expression of LGR5 in FGF4-treated cells was significantly lower than that in FGF2-treated cells (Fig. 2B) . Under all conditions, these mRNA expression levels were higher than those in undifferentiated human iPS cells. No effects of Wnt3a were observed on mRNA expression of CDX2 or
LGR5 during the early stages of differentiation. Differentiation into enterocyte-like cells: To effectively differentiate human iPS cells into enterocyte-like cells, we examined TCCTTTGCTCTGCGGTTCT  232  LGR5  TGCTCTTCACCAACTGCATC  CTCAGGCTCACCAGATCCTC  193  DPP4  CAAATTGAAGCAGCCAGACA  GGAGTTGGGAGACCCATGTA  212  Sucrase-isomaltase  GGTAAGGAGAAACCGGGAAG  GCACGTCGACCTATGGAAAT  195  Villin 1  AGCCAGATCACTGCTGAGGT  TGGACAGGTGTTCCTCCTTC  169  ISX  CAGGAAGGAAGGAAGAGCAA  TGGGTAGTGGGTAAAGTGGAA  96  CYP3A4  CTGTGTGTTTCCAAGAGAAGTTAC  TGCATCAATTTCCTCCTGCAG  298  SLC15A1/PEPT1  CACCTCCTTGAAGAAGATGGCA  GGGAAGACTGGAAGAGTTTTATCG  105  SLC46A1/PCFT  GGTCTTTGCCTTTGCCACTA  AGAGTTTAGCCCGGATGACA  98  GAPDH  GAGTCAACGGATTTGGTCGT  GACAAGCTTCCCGTTCTCAG the effects of FBS concentration in the differentiation medium. Expression of LGR5 in differentiated human iPS cells did not differ in the presence of 2% or 10% FBS (Fig. 3A) . However, mRNA expression of sucrase-isomaltase was 3.5-fold higher in 2% FBS than that in 10% FBS (Fig. 3B) . In addition, mRNA expression levels of SLC15A1/peptide transporter 1 (PEPT1) and CYP3A4 were higher in the presence of 2% FBS (Figs. 3C and  3D) . In differentiated enterocyte-like cells, sucrase-isomaltase and CYP3A4, which were not detected in undifferentiated human iPS cells, were expressed, and mRNA expression levels of LGR5 and SLC15A1/PEPT1 were 30-40-fold higher than those in undifferentiated human iPS cells. Morphological changes in differentiating human iPS cells are shown in Figure 4 . Similar to ES cells, undifferentiated human iPS cells had little cytoplasm and were small in size (Fig. 4A) . When human iPS cells were cultured in the presence of activin A and FGF2, the cells gradually exhibited morphological changes such as enlargement and acquisition of spiky shapes (Fig. 4B) . At the final stage of differentiation with EGF and 2% FBS, a number of dome-like structures formed and were assumed to contain liquids and cells (Figs. 4C and 4D) . In cells differentiated with activin A, FGF2, EGF, and 2% FBS, villin 1 28, 29) and intestine specific homeobox (ISX) 30) were expressed, whereas intestinal fatty acid-binding protein (IFABP) was not expressed. Interestingly, mRNA expression levels of CDX2, dipeptidyl peptidase 4 (DPP4), and SLC46A1/proton-coupled folate transporter (PCFT) were similar to those in the adult small intestine, which was used as a positive control (Fig. 5) . However, gene expression levels of UGT1A1 and ABCB1/multidrug resistance 1 (MDR1) were similar to those in undifferentiated human iPS cells (data not shown).
To determine the optimal duration of differentiation, we examined time-dependent variations in expression levels of specific small intestine genes such as LGR5, sucrase-isomaltase, and SLC15A1/PEPT1. After short-term culture (11 days), mRNA expression levels of sucrase-isomaltase and SLC15A1/PEPT1 were very low but gradually increased with differentiation until day 26. Similarly, CYP3A4 mRNA was not expressed after 11 days of differentiation but was expressed after 20 days (Fig. 6). LGR5 mRNA did not change with the duration of differentiation.
Immunofluorescence staining of sucrase-isomaltase in enterocyte-like cells: Sucrase-isomaltase is an essential carbohydrate digestion enzyme that is specifically expressed in brush border membranes of mature enterocytes. Therefore, sucrase-isomaltase expression is thought to be an indicator of differentiation into enterocytes. Indeed, protein expression of sucrase-isomaltase was confirmed in differentiated cells using immunofluorescence staining, in particular, in dense clusters of cells (Fig. 7) .
Uptake of ¢-Ala-Lys-AMCA in enterocyte-like cells: Oligopeptide transporters are expressed in the brush border membrane and participate in peptide absorption from the intestinal lumen. 2) As shown in Figure 3C , expression of SLC15A1/PEPT1 mRNA in differentiated enterocyte-like cells was more than 30-fold higher than that in undifferentiated human iPS cells. To determine whether this leads to active peptide transport in differentiated cells, we performed peptide uptake assays using ¢-Ala-Lys-AMCA, a fluorescence-labeled substrate of the oligopeptide transporter. 31) As shown in Figure 8 , intracellular uptake of ¢-Ala-Lys-AMCA was observed in cells expressing the sucrase-isomaltase proteins. However, uptake of ¢-Ala-Lys-AMCA at 4°C was low compared with that at 37°C (data not shown). 
Discussion
Ueda et al. 14) reported the synthesis of gut-like organs from mouse iPS cells using the EB formulation technique with mouse ES cells. However, this hanging drop culture technique is hampered by its high requirement of skill, low EB formulation efficiency, unstable EB quality, and differing differentiation efficiencies between EBs. Spence et al. 15) reported the direct differentiation of human iPS cells into three-dimensional intestinal organoids. These organoids contained various cell types, including enterocytes, endocrine cells, goblet cells, and Paneth cells, although expression of drug-metabolizing enzymes and transporters, which are central to drug absorption and metabolism, was not examined. In their study, the intestinal crypt culture system, in which spheroids 6 . Time-dependent variation in mRNA expression levels of sucraseisomaltase, SLC15A1/PEPT1, CYP3A4, and LGR5 in differentiated enterocyte-like cells Human iPS cells were cultured in the presence of activin A for 3 days. The cells were further cultured in medium containing FGF2 for 4 days and then in the presence of 2% FBS and EGF for 4, 13, or 19 days. After 11, 20, or 26 days of differentiation, total RNA was extracted and mRNAs were analyzed by SYBR Green real-time RT-PCR. mRNA expression levels were normalized relative to that of GAPDH. Gene expression levels are represented relative to the level in the adult small intestine, which is set as 100. The adult small intestine was used as a positive control. Data are presented as the mean « S.D. (n = 4) except for the adult small intestine. N.D., not detected. Levels of statistical significance were compared among all groups: **p < 0.01. 
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are formed by three-dimensional culture, was applied during differentiation from the endoderm to intestinal organoids, and several factors were added in large quantities to induce differentiation. This method may be suitable for the culture of intestinal stem cells but not for selective differentiation into enterocytes, and it is complicated and costly. Therefore, we generated enterocytelike cells using a simple two-dimensional culture method.
Spence et al. 15) also reported that the combination of FGF4 (500 ng/ml) and Wnt3a (500 ng/ml) effectively posteriorized the endoderm. Ameri et al. 32) reported the induction of CDX2 with FGF2 (256 ng/ml) in a concentration-dependent manner in the human ES cell-derived endoderm. In the present study, we examined the effects of FGF2, FGF4, and Wnt3a on the induction of the midgut endoderm lineage. Our results showed that the expression level of CDX2 was comparable in the FGF2 and FGF4 treatment groups, whereas no effect of Wnt3a was observed. These results were inconsistent with those of Spence et al., 15) possibly because of the lower concentrations of Wnt3a used in our study (50 ng/ml). Sherwood et al. 33) demonstrated that ¢-catenin-dependent Wnt signaling, activated by the glycogen synthase kinase-3 (GSK3) inhibitor, induced the expression of the intestinal master regulator Cdx2 and induced intestinal differentiation of the ES cell-derived endoderm and large intestinal gene expression. They also indicated that because of poor bioactivity, the induction level of Cdx2 expression by Wnt3a was lower than that by the GSK3 inhibitor. Therefore, superior stability and bioactivity of small-molecule compounds may lead to more effective experimental regulation of these signaling pathways. However, the striking activation of Wnt signaling also induced large intestinal gene expression, and further investigations of the extent of activation of Wnt signaling during small intestinal differentiation may be required. The expression of LGR5 17) was higher in the FGF2 treatment group than that in the FGF4 treatment group. Therefore, subsequent differentiation experiments were performed using FGF2.
We have demonstrated that enterocyte-like cells, which express the specific intestinal markers sucrase-isomaltase, 34, 35) villin 1, ISX, and pharmacokinetics-related genes, were differentiated from an intestinal stem cell-like cell population by two-dimensional culture with EGF and a low serum concentration. Sucrase-isomaltase and SLC15A1/PEPT1 mRNA gradually increased with the duration of differentiation, indicating that longer duration may be necessary to efficiently obtain mature enterocytes. In contrast, LGR5 mRNA expression remained unchanged, suggesting that enterocytes matured during intestinal stem cell proliferation. DPP4 (serine protease) and SLC46A1/PCFT (folate transporter) are known to be abundantly expressed in epithelial cells of the small intestine. 36, 37) Expression of DPP4 and SLC46A1/PCFT in differentiated cells was higher than that in adult small intestine samples. Intestinal differentiation was promoted by low FBS concentrations in this study. Potentially, the growth of extra-enterocytic cells such as fibroblasts may be suppressed with decreasing FBS concentrations, and some differentiation and growth-inhibiting factors may be present in FBS, although the mechanisms underlying these effects remain unclear.
At present, human intestinal epithelial cells are difficult to obtain, and no appropriate model cell system exists. Instead, other tissue cell-derived cell lines, including Caco-2 cells (human colon carcinoma cell line) and Madin-Darby canine kidney (MDCK) cells, have been used as intestinal models in drug absorption studies. 2, 38) However, drug transporter expression patterns in these cells considerably differ from those in enterocytes. In particular, CYP3A4 is expressed at very low levels in these cell lines. In the present study, cells expressing the sucrase-isomaltase protein showed uptake of ¢-Ala-Lys-AMCA, the substrate of the oligopeptide transporter (Fig. 8) . Differentiated cells also expressed CYP3A4 mRNA, albeit at levels lower than those in the adult small intestine (Fig. 3) , suggesting that enterocyte-like cells differentiated from human iPS cells have peptide-transporting activity and may be useful in the study of drug absorbability.
In this study, we used a human iPS cell line, which is easily differentiated into hepatocytes of an endodermal lineage, because the intestine is also an endoderm-derived tissue. Differentiation propensity is known to be markedly different among human ES and iPS cell lines. 39, 40) Thus, there may be a difference in the degree of intestinal differentiation depending on the human iPS cell line being tested. Regarding this point, we believe it is necessary to perform studies comparing intestinal differentiation among human iPS cell lines in the future.
In conclusion, because the intestine is an endoderm-derived tissue, human iPS cells were directly differentiated into the endoderm using activin A. Subsequently, we devised a simple method for differentiation into enterocyte-like cells with functional peptide transport by two-dimensional culture and the addition of several growth factors. These data suggest that human iPSderived enterocytes may facilitate future drug development studies. If enterocyte-like cells, which have functional features similar to those of enterocytes, can be generated from human iPS cells, it may be possible to construct systems for easy estimation of overall intestinal function, including absorption and metabolism.
